About James Clarke
James Clarke is a director at Biolexis Therapeutics.
Experience
This experience comes from James Clarke's profile and from SEC filings. For roles taken from filings, the years are when the filings name James Clarke in the role, so the role may have started earlier or lasted longer.
Biolexis Therapeutics Inc. Current
Director
2023 – Present · Lehi, UT
Develops oral drug candidates for people with obesity and type 2 diabetes.
CP
Clarke Capital Partners Current
Founder/Managing Partner
2004 – Present
CL
Clearlink
Founder & Stakeholder
2001 – 2026
BI
Brandless, Inc.
Chairman Of The Board
2020 – 2025
JP
Jupiter Acquisition Corporation (NSDQ:JAQCU) $157 M raised through several institutional partners
Vice Chair Board Of Directors
2021 – 2023
UU
Utah Valley University
Chairman, Foundation Board
2014 – 2020
PE
PetIQ
Chairman 2011-2016, Board Member (NSDQ: PETQ + Take Private at $2 Billion Total EV)
2011 – 2020
CU
Curza
Chairman Of The Board
2013 – 2019
PP
Perfectly Posh
Board of Directors
2011 – 2018
CO
Contour
Chairman of the Board
2011 – 2018
BF
Bridle Up Hope: The Rachel Covey Foundation
Member Board of Advisors
2014 – 2016
EB
eLearning Brothers
Board Member
2014 – 2016
UB
Utah State Bar
Future's Commission
2014 – 2015
IF
Innovative FlexPak
Investor/Board
2011 – 2014
BI
BYU-Idaho
President's Advancement Council
2011 – 2014
CP
CLARIAN PARTNERS
Founder/Managing Director
2008 – 2010
UO
Utah Symphony & Opera
Board Trustee
2007 – 2010
UA
Utah Museum of Fine Arts
Young Benefactors Advisor
2004 – 2009
KU
Kingsbury Hall-University-Utah
Board of Advisors
2004 – 2006
Key Colleagues at Startups
The people James Clarke works with at each company, as listed on that company's latest Form D.
Biolexis Therapeutics Inc. · Form D, Jun 3, 2026
Tyler Hartmann
President
Hariprasad Vankayalapati
Co-founder · Chief Scientific Officer and director
AS
Anthony Steve
Director
David Bearss
Co-founder · Chairman